Orexin/Hypocretin Neurons

Orexin/Hypocretin Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Orexin/Hypocretin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neuropeptide Neurons</td>
</tr>
<tr>
<td class="label">Neuropeptides</td>
<td>Orexin-A (hypocretin-1), Orexin-B (hypocretin-2)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>OX1R (HCRTR1), OX2R (HCRTR2)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Lateral hypothalamus, Perifornical area</td>
</tr>
<tr>
<td class="label">Neuron Count</td>
<td>~70,000 neurons in human brain</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Allen Brain Cell Atlas</td>
<td>[Search](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[Search](https://www.ebi.ac.uk/ols4/ontologies/cl/)</td>
</tr>
<tr>
<td class="label">Human Cell Atlas</td>
<td>[Search](https://www.humancellatlas.org/)</td>
</tr>
<tr>
<td class="label">CellxGene Census</td>
<td>[Search](https://cellxgene.cziscience.com/)</td>
</tr>
<tr>
<td class="label">Peptide</td>
<td>Alias</td>
</tr>
<tr>
<td class="label">Orexin-A</td>
<td>Hypocretin-1</td>
</tr>
<tr>
<td class="label">Orexin-B</td>
<td>Hypocretin-2</td>
</tr>
</table>

Introduction

Orexin/Hypocretin Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Orexin/Hypocretin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neuropeptide Neurons</td>
</tr>
<tr>
<td class="label">Neuropeptides</td>
<td>Orexin-A (hypocretin-1), Orexin-B (hypocretin-2)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>OX1R (HCRTR1), OX2R (HCRTR2)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Lateral hypothalamus, Perifornical area</td>
</tr>
<tr>
<td class="label">Neuron Count</td>
<td>~70,000 neurons in human brain</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Allen Brain Cell Atlas</td>
<td>[Search](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[Search](https://www.ebi.ac.uk/ols4/ontologies/cl/)</td>
</tr>
<tr>
<td class="label">Human Cell Atlas</td>
<td>[Search](https://www.humancellatlas.org/)</td>
</tr>
<tr>
<td class="label">CellxGene Census</td>
<td>[Search](https://cellxgene.cziscience.com/)</td>
</tr>
<tr>
<td class="label">Peptide</td>
<td>Alias</td>
</tr>
<tr>
<td class="label">Orexin-A</td>
<td>Hypocretin-1</td>
</tr>
<tr>
<td class="label">Orexin-B</td>
<td>Hypocretin-2</td>
</tr>
</table>

Introduction

Orexin (also known as hypocretin) neurons are a population of specialized neurons located in the lateral hypothalamus that play critical roles in regulating wakefulness, arousal, appetite, and energy homeostasis[@saper2010]. These neurons are essential for maintaining normal sleep-wake cycles, and their degeneration is strongly implicated in narcolepsy. Additionally, orexin system dysfunction has been increasingly recognized in neurodegenerative diseases, particularly Parkinson's disease[@fronczek2007]. [@saper2010]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [Cell Ontology](https://www.ebi.ac.uk/ols4/ontologies/cl/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Neuroanatomy

Location and Connectivity

Orexin neurons are primarily located in:

• Lateral Hypothalamus (LH): Main population
• Perifornical Area (PeF): Dorsomedial to the fornix
• Dorsomedial Hypothalamus (DMH): Minor population

• Ascending projections: To basal forebrain, cortex, thalamus
• Descending projections: To brainstem, spinal cord
• Key targets: Locus coeruleus, dorsal raphe, tuberomammillary nucleus, ventral tegmental area

Cellular Properties

Orexin neurons exhibit unique electrophysiological characteristics:

• Spontaneous firing: Tonic activity during wakefulness
• Quiet periods: Reduced firing during sleep
• Intracellular calcium: High baseline calcium levels
• Metabolic sensing: Respond to glucose, leptin, ghrelin

Neurochemistry

Orexin Peptides

Two related neuropeptides are produced:

Receptor Pharmacology

• OX1R (HCRTR1): Prefers orexin-A; expressed in locus coeruleus, amygdala
• OX2R (HCRTR2): Binds both orexin-A and orexin-B; expressed in hypothalamus, cortex

Physiological Functions

Wakefulness and Arousal

Orexin neurons are the central driver of arousal:

Energy Homeostasis

Orexin neurons integrate metabolic signals:

• Glucose sensing: Respond to changes in extracellular glucose
• Leptin signaling: Receive input from leptin (satiety hormone)
• Ghrelin signaling: Respond to ghrelin (hunger hormone)
• Energy expenditure: Increase motor activity and thermogenesis

Appetite Regulation

Orexin promotes food-seeking behavior:

• Increase appetite: Direct orexigenic effect
• Food motivation: Enhance reward-driven feeding
• Energy balance: Coordinate feeding with energy expenditure

Disease Relevance

Narcolepsy

Narcolepsy type 1 (with cataplexy) is characterized by:

• Orexin neuron loss: ~90% loss of orexin neurons
• CSF orexin-A: Undetectable or very low (<110 pg/mL)
• Autoimmune hypothesis: T-cell mediated destruction
• HLA association: DQB1*06:02 susceptibility

Parkinson's Disease

Emerging evidence links orexin dysfunction to PD:

• Orexin neuron loss: Reduced orexin neurons in PD brains
• Sleep fragmentation: Common in PD, orexin may contribute
• Cognitive decline: Low orexin-A correlates with dementia in PD
• REM sleep behavior disorder: Often precedes PD, orexin involvement

Alzheimer's Disease

In AD, orexin system changes include:

• Elevated orexin-A: CSF levels increased in AD
• Sleep disruption: Common in AD, orexin may contribute
• Amyloid interaction: Orexin may affect Aβ metabolism

Other Disorders

• Obesity: Reduced orexin signaling may contribute
• Depression: Altered orexin function in some patients
• Addiction: Orexin in reward and reinforcement

Therapeutic Implications

Narcolepsy Treatments

Current and emerging therapies:

• Orexin receptor agonists: Small molecule orexin mimetics
• Histamine H3 antagonists: Promote wakefulness indirectly
• Sodium oxybate: For cataplexy and sleep paralysis

Neurodegeneration Research

Potential therapeutic approaches:

• Orexin receptor modulators: For PD sleep disorders
• Orexin-A administration: Potential neuroprotective effects
• Combination therapies: Target orexin + other systems

Animal Models

Genetic Models

• Orexin/ataxin-3 mice: Progressive orexin neuron loss
• Orexin knockout mice: Narcolepsy-like phenotype
• Orexin receptor knockout mice: Sleep-wake abnormalities

Pharmacological Models

• Orexin-A/B antagonists: SB-9200, Suvorexant
• Orexin receptor agonists: For wake promotion

See Also

• Orexin Receptors
• [Narcolepsy](/diseases/narcolepsy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Hypothalamic-Pituitary Axis
• [Sleep Disorders in Neurodegeneration](/mechanisms/sleep-disorders-neurodegeneration)
• Wakefulness Pathways

• Orexin Receptors IUPHAR: [https://www.guidetopharmacology.org/1362](https://www.guidetopharmacology.org/1362)
• Sleep Research Society: [https://sleepresearchlibrary.org/](https://sleepresearchlibrary.org/)
• NIH Narcolepsy Information: [https://www.ninds.nih.gov/narcolepsy](https://www.ninds.nih.gov/narcolepsy)

Background

The study of Orexin Hypocretin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.